EntrepreneurialCheck
Stephanie Culler estimated net worth profile

Stephanie Culler net worth

Stephanie Culler Net Worth 2026 (Estimated) · CEO at Persephone Biosciences · YC W18
est. wealth $90.0M

Quick answer

Stephanie Culler's estimated net worth is $90.0M (range $63.0M – $135.0M) as of 2026. Stephanie Culler is CEO at Persephone Biosciences. Persephone Biosciences valuation.

Stephanie Culler is CEO at Persephone Biosciences (YC W18). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameStephanie Culler
RoleCEO
CompanyPersephone Biosciences
YC batchW18
Est. company val$150.0M
Assumed ownership60%
Est. paper wealth / net worth$90.0M
$63.0M – $135.0M
  • Company status: Active
  • Education: Stanford University
  • Region: United States of America
  • Industries: Healthcare, Therapeutics
  • Team size: 6
  • Website: http://persephonebiosciences.com/

Who is Stephanie Culler?

Stephanie Culler is a co-founder of Persephone Biosciences, a startup aimed at advancing microbiome research.

Highlights:

  • Stanford University
  • Y Combinator W18
  • Microbiome research advocate

About Persephone Biosciences

Persephone Biome develops live biotherapeutic products to modulate the metabolism of gut microbes, for applications in disease prevention and cure. We take a unique engineering approach using systems and synthetic biology to understand the complexities of the microbiome.

FAQ: Stephanie Culler net worth and Persephone Biosciences valuation

What is Stephanie Culler's net worth?

Stephanie Culler's estimated net worth is $90.0M (range $63.0M – $135.0M) as of 2026. Stephanie Culler is CEO at Persephone Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Persephone Biosciences valuation?

Persephone Biosciences's estimated valuation on Entrepreneurial Check is $150.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Stephanie Culler's role?

Stephanie Culler is CEO at Persephone Biosciences, a Y Combinator-backed startup (batch W18).